Society of Diabetic Nephropathy Prevention Journal of Nephropharmacology 2345-4202 14 1 2025 01 01 Acute kidney injury following cancer immunotherapy; collaboration of oncologists and nephrologists e12696 e12696 10.34172/npj.2024.12696 EN Sousan Mohammadi Kebar https://orcid.org/0000-0001-8043-9264 Saeed Hoseininia https://orcid.org/0000-0002-8816-3378 Journal Article 10.34172/npj.2024.12696 2024 05 18 2024 07 01 Acute kidney injury (AKI) is a known complication of cancer immunotherapy, which is a type of cancer treatment that uses the body’s immune system to fight cancer cells. The mechanism of acute kidney injury (AKI) in cancer immunotherapy is thought to be related to the immune-mediated inflammation and cytokine release that can occur with immunotherapy. This inflammation can damage the kidney tubules and impair kidney function.